BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,090 filers reported holding BAXTER INTL INC in Q2 2021. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,062 | -53.2% | 1,300 | -43.5% | 0.01% | -53.8% |
| Q2 2023 | $104,788 | +12.3% | 2,300 | 0.0% | 0.01% | +18.2% |
| Q1 2023 | $93,288 | -20.4% | 2,300 | 0.0% | 0.01% | -21.4% |
| Q4 2022 | $117,231 | -5.5% | 2,300 | 0.0% | 0.01% | -51.7% |
| Q3 2022 | $124,000 | -16.2% | 2,300 | 0.0% | 0.03% | +61.1% |
| Q2 2022 | $148,000 | -16.9% | 2,300 | 0.0% | 0.02% | -5.3% |
| Q1 2022 | $178,000 | -84.2% | 2,300 | -82.5% | 0.02% | -86.9% |
| Q4 2021 | $1,129,000 | +72.1% | 13,150 | +61.3% | 0.14% | +62.9% |
| Q3 2021 | $656,000 | -38.1% | 8,151 | -38.0% | 0.09% | -30.5% |
| Q2 2021 | $1,059,000 | -4.5% | 13,150 | 0.0% | 0.13% | +21.9% |
| Q1 2021 | $1,109,000 | -9.4% | 13,150 | -13.8% | 0.10% | -36.0% |
| Q4 2020 | $1,224,000 | +12.3% | 15,250 | +12.5% | 0.16% | -5.2% |
| Q3 2020 | $1,090,000 | -23.8% | 13,550 | -18.5% | 0.17% | -24.8% |
| Q2 2020 | $1,431,000 | +18.7% | 16,622 | +11.9% | 0.23% | +0.9% |
| Q1 2020 | $1,206,000 | -15.4% | 14,853 | -12.9% | 0.23% | +4.1% |
| Q4 2019 | $1,426,000 | +5.2% | 17,050 | +10.0% | 0.22% | -0.9% |
| Q3 2019 | $1,356,000 | +6.9% | 15,500 | 0.0% | 0.22% | +5.2% |
| Q2 2019 | $1,269,000 | -0.3% | 15,500 | -1.0% | 0.21% | -3.2% |
| Q1 2019 | $1,273,000 | +19.0% | 15,650 | -3.7% | 0.22% | +7.4% |
| Q4 2018 | $1,070,000 | -14.6% | 16,250 | 0.0% | 0.20% | 0.0% |
| Q3 2018 | $1,253,000 | +4.4% | 16,250 | 0.0% | 0.20% | +2.0% |
| Q2 2018 | $1,200,000 | +13.5% | 16,250 | 0.0% | 0.20% | +23.8% |
| Q1 2018 | $1,057,000 | -4.7% | 16,250 | -5.2% | 0.16% | -7.0% |
| Q4 2017 | $1,109,000 | +3.1% | 17,150 | 0.0% | 0.17% | -2.8% |
| Q3 2017 | $1,076,000 | +3.7% | 17,150 | 0.0% | 0.18% | +4.7% |
| Q2 2017 | $1,038,000 | +13.4% | 17,150 | -2.8% | 0.17% | +14.2% |
| Q1 2017 | $915,000 | +2.9% | 17,650 | -12.0% | 0.15% | +0.7% |
| Q4 2016 | $889,000 | -12.5% | 20,051 | -6.1% | 0.15% | -16.9% |
| Q3 2016 | $1,016,000 | +76.1% | 21,350 | +67.5% | 0.18% | +80.6% |
| Q2 2016 | $577,000 | +10.1% | 12,750 | 0.0% | 0.10% | +6.5% |
| Q1 2016 | $524,000 | +7.8% | 12,750 | 0.0% | 0.09% | +12.2% |
| Q4 2015 | $486,000 | +16.8% | 12,750 | +0.8% | 0.08% | +13.9% |
| Q3 2015 | $416,000 | -73.7% | 12,650 | -44.2% | 0.07% | -70.2% |
| Q2 2015 | $1,584,000 | -3.8% | 22,650 | -5.8% | 0.24% | -2.0% |
| Q1 2015 | $1,647,000 | -6.6% | 24,050 | 0.0% | 0.25% | -11.8% |
| Q4 2014 | $1,763,000 | +2.1% | 24,050 | 0.0% | 0.28% | -2.1% |
| Q3 2014 | $1,726,000 | +25.3% | 24,050 | +26.2% | 0.29% | +32.4% |
| Q2 2014 | $1,377,000 | +3.7% | 19,050 | +5.5% | 0.22% | -4.8% |
| Q1 2014 | $1,328,000 | -11.4% | 18,050 | -16.2% | 0.23% | -15.6% |
| Q4 2013 | $1,499,000 | +3.5% | 21,550 | -2.3% | 0.27% | -2.9% |
| Q3 2013 | $1,448,000 | -6.0% | 22,050 | -0.9% | 0.28% | +1.5% |
| Q2 2013 | $1,541,000 | – | 22,250 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |